RaySearch Laboratories AB (publ) (FRA:27R)

Germany flag Germany · Delayed Price · Currency is EUR
30.75
-0.60 (-1.91%)
At close: Jul 14, 2025, 10:00 PM CET
Market Cap1.10B
Revenue (ttm)116.74M
Net Income (ttm)20.61M
Shares Outn/a
EPS (ttm)0.60
PE Ratio53.24
Forward PEn/a
Dividend0.28 (0.90%)
Ex-Dividend DateMay 23, 2025
Volume120
Average Volume124
Open30.75
Previous Close31.35
Day's Range30.75 - 30.75
52-Week Range10.82 - 31.35
Betan/a
RSI65.53
Earnings DateAug 8, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation... [Read more]

Industry Prepackaged Software
Founded 2000
Employees 416
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 27R
Full Company Profile

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.